Elena G. G.
- Country
- Spain
- Department
- Digestive, Endocrine and Abdominal Organ Transplant Surgery
Research Overview
Data & Insights
Has run more than one trial at 0 of 15 partner sites.
Specializations
Abdominal Organ Transplantation
The investigator concentrates on surgical techniques and peri‑operative care for liver and kidney transplantation, emphasizing graft preservation and immune modulation.
- Living donor liver transplantation
- Kidney graft allocation strategies
- Post‑transplant infection prophylaxis
Her work supports improved long‑term graft survival in the Mediterranean region.
Digestive and Metabolic Surgery
Focused on operative management of complex gastrointestinal disorders and metabolic disease, she integrates minimally invasive approaches for obesity and type 2 diabetes.
- Bariatric procedures with metabolic outcomes
- Pancreatic resections for neoplasia
- Enhanced recovery pathways in colorectal surgery
These initiatives aim to reduce postoperative complications and improve metabolic control.
Cardiovascular Disease Management
Her clinical interests include prevention and treatment of atherosclerotic cardiovascular disease, with a special focus on high‑risk cohorts and novel lipid‑lowering strategies.
- Primary prevention in patients with elevated lipoprotein(a)
- Management of acute coronary syndromes
- Therapeutic approaches to heart failure with preserved ejection fraction
She collaborates across cardiology and surgery to optimize cardiovascular outcomes.
Oncology – Solid Tumors and Breast Cancer
In the oncology arena, she addresses multidisciplinary care for breast cancer and advanced solid malignancies, integrating surgical oncology with systemic therapies.
- Neoadjuvant and adjuvant strategies for HER2‑negative breast cancer
- Resection techniques for pancreatic and gastric adenocarcinoma
- Multimodal treatment of metastatic melanoma
Her contributions facilitate personalized treatment pathways for complex tumor cases.
Hematologic Malignancies and Immunotherapy
She engages in the therapeutic development for hematologic cancers, emphasizing targeted and cellular immunotherapies for conditions such as acute myeloid leukemia and non‑Hodgkin lymphoma.
- CAR‑T cell strategies for refractory B‑cell lymphomas
- Targeted kinase inhibitors in acute leukemias
- Maintenance regimens after autologous stem cell transplant
These efforts aim to expand curative options for patients with high‑risk hematologic disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.